Centre Hospitalier Affilie Universitaire De Quebec, Hospital du St-Sacrement

Québec, Quebec G1S 4L8

0 studies enrolling now · 2 studies all time

What they study most

Breast Cancer, Invasive Breast Cancer

Studies at this site

• BETH Study: Treatment of HER2 Positive Breast Cancer With Chemotherapy Plus Trastuzumab vs Chemotherapy Plus Trastuzumab Plus Bevacizumab — Stopped early
• A Study of AC Followed by a Combination of Paclitaxel Plus Trastuzumab or Lapatinib or Both Given Before Surgery to Patients With Operable HER2 Positive Invasive Breast Cancer — Status unconfirmed